# Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

> **NCT00937079** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 30 (actual)

## Conditions studied

- Hyperinsulinism
- Hypoglycemia
- Insulinoma

## Interventions

- **OTHER:** 111In-exendin-4 imaging

## Key facts

- **NCT ID:** NCT00937079
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00937079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00937079, "Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00937079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
